breast cancer - triple negative | breast cancer HER 2 negative | |
es-BC - TNBC - NA - all population | mBC - HER 2 negative | |
durvalumab alone | GeparNuevo | Saphir02 Breast-Immuno |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -